Transcript Module 6 - CD-JEV AEFI monitoring pptx, 243kb

CD-JEV Japanese Encephalitis Vaccine Introduction
Training Modules for Health Care Workers
Module 6
CD-JEV AEFI monitoring
Learning objectives
 At the end of the module, the participant will be
able to:
– Identify adverse events following immunization
(AEFIs).
– Explain how to report AEFIs.
 Duration:
– 15 minutes
2 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
Key issues
1
2
What are the AEFIs of
CD-JEV vaccine?
How do I report an AEFI?
3 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
What is an AEFI?
 AEFI = Adverse event following immunization.
 Any untoward medical occurrence which follows immunization
and which does not necessarily have a causal relationship
with the usage of the vaccine.
 AEFIs can be categorized into:
–
–
–
–
–
–
Reaction related to vaccine product.
Reaction related to vaccine quality defect.
Reaction related to immunization error.
Reaction related to immunization anxiety.
Coincidental event.
Unknown.
4 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
What is the risk of AEFIs with
CD-JEV vaccine?
 CD-JEV is “prequalified” by WHO, which means the vaccine has been
assessed by the WHO and meets high safety standards for the target
population.
 Local reactions at the injection site such as redness and swelling have
been reported in 1% to 15% of vaccine recipients.
 Systemic reactions such as mild fever, irritability, nausea and dizziness
have been very rarely reported; high fever was reported in 5% to 20% of
recipients.
 Few allergic reactions have been reported with CD-JEV.
 If a child becomes severely ill or appears to have an allergic reaction in
the days following the immunization, the parent should bring the child to a
hospital or clinic as soon as possible.
5 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
How to report an AEFI (1/2)
 Report the identified AEFI through existing AEFI
reporting systems established by national immunization
programmes.
 In addition to vaccine reactions, AEFIs can include
programme errors or injection reactions, or reasons can
be coincidental or unknown.
 Immediately report and refer for medical treatment if a
child develops a condition such as fever higher than
38.5⁰C or a severe hypersensitivity reaction.
6 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
How to report an AEFI (2/2)

The AEFI report should be completed thoroughly and
contain:
o Place of vaccination.
o Name of reporting officer.
o Patient name and details about vaccination.
o Patient information prior to immunization.
o Details of first examination of serious AEFI case.
o Details of vaccines provided at the site that are linked to AEFI on the
corresponding day.
o Immunization practices where AEFI-related vaccine was used.
o Cold chain and transport details.
o What community investigation was done.
7 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
Key messages
 CD-JEV has been assessed by the WHO and meets high safety
standards for the target population.
 In addition to vaccine reactions, AEFIs can include programme errors
or injection reactions, or reasons can be coincidental or unknown.
 If a child becomes severely ill or appears to have an allergic reaction
in the days following the immunization, the parent or caregiver should
bring the child to a hospital or clinic as soon as possible.
 Report AEFIs through existing reporting systems established by the
national immunization programme; make sure the report is filled out
completely.
8 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016
End of module
Thank you
for your attention!
 Next is Module 7: CD-JEV
vaccine communication with
caregivers
9 | CD-JEV AEFI monitoring, Module 6 |
24 July 2016